MDS 2017

Treating Movement Disorders With Telemedicine: Getting Started

Treating Movement Disorders With Telemedicine: Getting Started

Jaime Hatcher-Martin, MD, PhD, a movement disorders specialist at Emory University Hospital and the founder of Emory's movement disorders telemedicine clinic, shares her personal experience with telemedicine and provides some guidance for clinicians who might be interested in exploring this treatment option to improve their patients' access to care. Scroll below the video to read the full transcript.

Using Speech Markers to Identify Cognitive, Motor Deficits in Parkinson's

Using Speech Markers to Identify Cognitive, Motor Deficits in Parkinson's

Kara Smith, MD, a movement disorders specialist at UMass Memorial Medical Center and an assistant professor at the University of Massachusetts Medical School, both in Worcester, discusses how a brief free speech sample might be used to calculate a patient's cognitive and motor scores. Scroll below the video to read the full transcript.

Investigational Therapy Reduces Tourette Tic Severity Without Adverse Effects

Investigational Therapy Reduces Tourette Tic Severity Without Adverse Effects

By

Nearly 40% of patients in the treatment group were "much" or "very much" improved at 4 weeks.

Deep Brain Stimulation Reduces Risk of Polypharmacy in Parkinson's

Deep Brain Stimulation Reduces Risk of Polypharmacy in Parkinson's

By

Patients who underwent deep brain stimulation were 94% less likely to require polypharmacy at 5 years.

Levodopa May Benefit Heart Health in Parkinson's Disease

Levodopa May Benefit Heart Health in Parkinson's Disease

By

Although nonmotor symptoms in Parkinson's have gained significant attention through the years, blood pressure changes have been overlooked.

Metabolic Syndrome May Have Role in Parkinson's Progression

Metabolic Syndrome May Have Role in Parkinson's Progression

By

Patients with metabolic syndrome experienced greater worsening of UPDRS scores over time compared with patients without metabolic syndrome.

Studies Highlight Positive Results for Deutetrabenazine for Tardive Dyskinesia

Studies Highlight Positive Results for Deutetrabenazine for Tardive Dyskinesia

By

Analyses of the ARM-TD and AIM-TD trials indicate that deutetrabenazine performs better than placebo as treatment for tardive dyskinesia.

Predicting Mortality in Parkinson's Disease: The Role of Motor Complications

Predicting Mortality in Parkinson's Disease: The Role of Motor Complications

By

Four-year results show that motor complications, but not burden of nonmotor symptoms, can predict death in patients with Parkinson's disease.

Neurofilament Light Chain to Predict Progression of Degenerative Brain Disorder

Neurofilament Light Chain to Predict Progression of Degenerative Brain Disorder

By

Previous research has shown that plasma neurofilament light chain concentration may predict severity of disease progression in progressive supranuclear palsy.

Gut Microbiota May Play a Role in Progression of Parkinson's Disease

Gut Microbiota May Play a Role in Progression of Parkinson's Disease

By

New research suggests that baseline gut microbiota may predict the progression of Parkinson's disease at 2 years.

Polyneuropathy May Signify More Severe Parkinson's Disease

Polyneuropathy May Signify More Severe Parkinson's Disease

By

While polyneuropathy is fairly common in Parkinson's disease, the etiology of the pain condition is not clear.

High Total Cholesterol Linked to Decreased Risk of Parkinson's Disease

High Total Cholesterol Linked to Decreased Risk of Parkinson's Disease

By

Researchers sought to better understand the potential role of cholesterol in the etiology of Parkinson's disease.

What to Expect: International Congress of Parkinson's Disease and Movement Disorders 2017

What to Expect: International Congress of Parkinson's Disease and Movement Disorders 2017

By

Learn more about what to expect from this year's International Congress of Parkinson's Disease and Movement Disorders.

Sign Up for Free e-newsletters